Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.5M Buy
45,639
+2,314
+5% +$498K 0.31% 55
2026
Q1
$9.42M Sell
43,325
-17,320
-29% -$3.84M 0.29% 56
2025
Q4
$13.9M Sell
60,645
-254
-0.4% -$57.9K 0.43% 45
2025
Q3
$14.1M Sell
60,899
-1,518
-2% -$309K 0.45% 52
2025
Q2
$11.6M Sell
62,417
-1,914
-3% -$356K 0.39% 62
2025
Q1
$13.5M Sell
64,331
-85
-0.1% -$16.5K 0.49% 53
2024
Q4
$11.4M Buy
64,416
+1,396
+2% +$257K 0.4% 64
2024
Q3
$12.4M Buy
63,020
+4,672
+8% +$872K 0.44% 60
2024
Q2
$10M Sell
58,348
-1,677
-3% -$278K 0.38% 71
2024
Q1
$10.9M Sell
60,025
-291
-0.5% -$50.2K 0.42% 60
2023
Q4
$9.35M Buy
60,316
+4,044
+7% +$590K 0.39% 66
2023
Q3
$8.39M Buy
56,272
+242
+0.4% +$35.5K 0.39% 66
2023
Q2
$7.55M Sell
56,030
-980
-2% -$144K 0.35% 76
2023
Q1
$9.09M Sell
57,010
-13,589
-19% -$2.08M 0.45% 58
2022
Q4
$11.4M Sell
70,599
-1,929
-3% -$296K 0.58% 39
2022
Q3
$9.73M Buy
72,528
+436
+0.6% +$62.6K 0.54% 49
2022
Q2
$11M Sell
72,092
-1,995
-3% -$305K 0.58% 41
2022
Q1
$12M Sell
74,087
-720
-1% -$105K 0.55% 45
2021
Q4
$10.1M Sell
74,807
-1,615
-2% -$191K 0.44% 65
2021
Q3
$8.24M Sell
76,422
-803
-1% -$91.8K 0.39% 73
2021
Q2
$8.7M Buy
77,225
+1,224
+2% +$138K 0.4% 70
2021
Q1
$8.22M Buy
76,001
+4,947
+7% +$529K 0.41% 74
2020
Q4
$7.61M Buy
71,054
+1,074
+2% +$103K 0.42% 72
2020
Q3
$6.13M Sell
69,980
-5,185
-7% -$488K 0.38% 77
2020
Q2
$7.38M Buy
75,165
+4,332
+6% +$381K 0.48% 55
2020
Q1
$5.4M Buy
70,833
+2,354
+3% +$201K 0.41% 77
2019
Q4
$6.06M Buy
68,479
+2,549
+4% +$212K 0.33% 96
2019
Q3
$4.99M Sell
65,930
-29,732
-31% -$2.04M 0.3% 109
2019
Q2
$6.96M Sell
95,662
-9,514
-9% -$748K 0.42% 79
2019
Q1
$8.48M Sell
105,176
-1,036
-1% -$84.8K 0.53% 52
2018
Q4
$9.79M Buy
106,212
+1,390
+1% +$122K 0.69% 33
2018
Q3
$9.91M Sell
104,822
-50,425
-32% -$4.78M 0.59% 43
2018
Q2
$14.4M Buy
155,247
+6,010
+4% +$587K 0.84% 25
2018
Q1
$14.1M Sell
149,237
-12,251
-8% -$1.35M 0.87% 25
2017
Q4
$15.6M Buy
161,488
+9,869
+7% +$930K 0.88% 26
2017
Q3
$13.5M Sell
151,619
-5,599
-4% -$426K 0.88% 27
2017
Q2
$11.4M Sell
157,218
-227
-0.1% -$15.3K 0.75% 44
2017
Q1
$10.3M Buy
157,445
+2,875
+2% +$181K 0.68% 50
2016
Q4
$9.68M Sell
154,570
-1,521
-1% -$92.8K 0.66% 54
2016
Q3
$10M Buy
156,091
+214
+0.1% +$13.9K 0.71% 46
2016
Q2
$9.65M Buy
155,877
+4,524
+3% +$276K 0.69% 47
2016
Q1
$8.64M Buy
151,353
+7,876
+5% +$439K 0.63% 59
2015
Q4
$8.43M Sell
143,477
-26
-0% -$1.5K 0.62% 56
2015
Q3
$7.81M Buy
143,503
+11,384
+9% +$741K 0.6% 60
2015
Q2
$8.88M Buy
132,119
+6,158
+5% +$402K 0.6% 56
2015
Q1
$7.37M Buy
125,961
+17,884
+17% +$1.08M 0.51% 67
2014
Q4
$7.07M Buy
108,077
+2,768
+3% +$175K 0.56% 58
2014
Q3
$6.08M Buy
105,309
+271
+0.3% +$15K 0.52% 66
2014
Q2
$5.93M Buy
105,038
+5,708
+6% +$299K 0.51% 66
2014
Q1
$5.11M Buy
99,330
+6,750
+7% +$341K 0.47% 72
2013
Q4
$4.89M Buy
92,580
+1,187
+1% +$58.3K 0.48% 68
2013
Q3
$4.09M Sell
91,393
-474
-0.5% -$21K 0.46% 74
2013
Q2
$3.8M Buy
+91,867
New +$4.02M 0.47% 73

Other funds holding ABBV

Burney Company's ABBV Position: Q2 2026 in Review

Burney Company increased its AbbVie (ABBV) stake by 5.3% in Q2 2026, buying an estimated $498K and bringing the position to 45,639 shares worth $11.5M. The position accounts for 0.31% of the portfolio, ranked #55.

Burney Company first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.6M in Q4 2017. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Burney Company held 45,639 shares of AbbVie worth $11.5M as of Q2 2026.
  • Burney Company bought 2,314 AbbVie shares in Q2 2026, an estimated $498K.
  • AbbVie made up 0.31% of Burney Company's portfolio in Q2 2026, its #55 holding.
  • Burney Company first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Burney Company's AbbVie position peaked at $15.6M in Q4 2017.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.